Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > LifeSci Communications

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 18, 2022 12:29pm

139 Views

Post# 34692649

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:LifeSci Communications

Forced? I don't think you fully understand the terms of the deal Money.

MoneyMouth wrote: They're gonna be even happier when they are forced to purchase shares at $2.50 at the end of August. I feel like this point is being glossed over. That's a 63% premium to what they bought at $1.57. I don't understand why that cold hard valuation isn't being reflected in the share price.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec